A detailed history of Canandaigua National Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Canandaigua National Corp holds 6,005 shares of NVO stock, worth $672,259. This represents 0.14% of its overall portfolio holdings.

Number of Shares
6,005
Previous 6,255 4.0%
Holding current value
$672,259
Previous $623,000 30.5%
% of portfolio
0.14%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$102.55 - $135.33 $25,637 - $33,832
-250 Reduced 4.0%
6,005 $813,000
Q1 2022

May 09, 2022

SELL
$93.1 - $112.54 $558,134 - $674,677
-5,995 Reduced 48.94%
6,255 $695,000
Q3 2021

Oct 04, 2021

BUY
$84.42 - $106.62 $1.03 Million - $1.31 Million
12,250 New
12,250 $1.18 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Canandaigua National Corp Portfolio

Follow Canandaigua National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.